Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

690.00 6.49 −0.93%
Market cap
$257.5B
P/E
37.1×
Fwd P/E
23.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

27.97 32.61 26.98 26.93
P/S ratio
4.19 4.90 4.05 4.01
P/FCF ratio
29.84 34.47 26.93 25.27
P/Operating CF
81.88 63.19 153.40 87.53
P/B ratio
3.59 4.09 3.52 3.53
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
4.84 5.48 4.86 4.77
EV/EBITDA
20.54 23.20 20.52 19.94
EV/Operating CF
27.66 31.24 26.51 24.53
EV/FCF
34.44 38.54 32.36 30.04
Quick Ratio
0.84 1.25 0.85 0.90
Current Ratio
1.50 1.89 1.53 1.55
Net Debt/EBITDA
10.88 8.63 14.16 12.09
Debt/Assets
30.92% 32.49% 35.37% 34.62%
Debt/Equity
0.62 0.67 0.77 0.74
Asset Turnover
0.43 0.43 0.43 0.43
Operating CF/Net income
1.39 1.76 0.72 1.22
Capex/Depreciation
(0.61) (0.60) (0.50) (0.55)
Interest Coverage
5.59 6.18 5.27 5.20
Research and Development Expense of Revenue
3.11% 2.92% 3.05% 3.03%
Selling, General and Administrative Expense of Revenue
19.44% 19.26% 19.82% 19.45%
Intangible Assets out of Total Assets
0.64 0.59 0.66 0.65
Share Based Compensation of Revenue
0.63% 0.69% 0.75% 0.68%
Graham Net Nets
(0.16) (0.13) (0.21) (0.20)
Graham Number
229.49 238.01 239.25 243.92
Earnings Yield
3.58% 3.07% 3.71% 3.71%
Free Cash Flow Yield
3.35% 2.90% 3.71% 3.96%
Revenue per Share
29.42 32.40 29.58 32.33
Operating CF per Share
5.92 9.17 3.20 5.73
Capex per Share
(1.06) (1.16) (0.99) (1.20)
Free Cash Flow per Share
4.87 8.01 2.22 4.53
Cash per Share
9.38 26.80 8.75 10.95
Shareholders Equity per Share
134.98 141.68 139.62 142.01
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
134.98 141.68 139.62 142.01
Free Cash Flow
1,839.00 3,019.00 825.00 1,679.00
Working Capital
7,407.00 13,518.00 7,695.00 8,296.00
Capital Expenditures
(400.00) (438.00) (367.00) (446.00)
Net Current Asset Value
(29,701.00) (28,221.00) (39,025.00) (37,123.00)
EV/EBIT
28.19 31.52 27.83 27.14
Capex to Sales
0.04 0.04 0.03 0.04
Price to Operating Income
24.42 28.20 23.16 22.83
Other line items
Average Receivables
8,583.00 8,545.50 8,829.50 9,022.50
Average Payables
2,863.00 3,350.50 3,196.50 3,124.00
Average Inventory
5,587.50 5,201.50 5,360.00 5,593.00
Average Assets
101,692.00 103,832.00 106,161.00 107,202.00
Average Common Equity
49,998.50 51,483.00 50,648.50 51,581.50

Fold the line items

Columns are period end dates